Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10374649
[patent_doc_number] => 20150259655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'CHROMOSOMAL MODIFICATION INVOLVING THE INDUCTION OF DOUBLE-STRANDED DNA CLEAVAGE AND HOMOLOGOUS RECOMBINATION AT THE CLEAVAGE SITE'
[patent_app_type] => utility
[patent_app_number] => 14/550463
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8961
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14550463
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/550463 | Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage site | Nov 20, 2014 | Issued |
Array
(
[id] => 10247850
[patent_doc_number] => 20150132847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'ENCAPSULATION AND CARDIAC DIFFERENTIATION OF hiPSCs IN 3D PEG-FIBRINOGEN HYDROGELS'
[patent_app_type] => utility
[patent_app_number] => 14/538435
[patent_app_country] => US
[patent_app_date] => 2014-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15753
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14538435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/538435 | Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels | Nov 10, 2014 | Issued |
Array
(
[id] => 11921644
[patent_doc_number] => 09789205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Compositions and methods for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 14/537547
[patent_app_country] => US
[patent_app_date] => 2014-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 37
[patent_no_of_words] => 29235
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537547
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/537547 | Compositions and methods for gene therapy | Nov 9, 2014 | Issued |
Array
(
[id] => 13011605
[patent_doc_number] => 10028902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure
[patent_app_type] => utility
[patent_app_number] => 15/034929
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 28187
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034929 | Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure | Nov 6, 2014 | Issued |
Array
(
[id] => 10241595
[patent_doc_number] => 20150126590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'GENE THERAPY FOR ALZHEIMER\'S AND OTHER NEURODEGENERATIVE DISEASES AND CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/530049
[patent_app_country] => US
[patent_app_date] => 2014-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11643
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14530049
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/530049 | Gene therapy for Alzheimer's and other neurodegenerative diseases and conditions | Oct 30, 2014 | Issued |
Array
(
[id] => 11177999
[patent_doc_number] => 09409982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Antibody composition-producing cell'
[patent_app_type] => utility
[patent_app_number] => 14/520528
[patent_app_country] => US
[patent_app_date] => 2014-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 74
[patent_no_of_words] => 77497
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14520528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/520528 | Antibody composition-producing cell | Oct 21, 2014 | Issued |
Array
(
[id] => 10361957
[patent_doc_number] => 20150246961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 14/517516
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22104
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517516
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/517516 | METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS | Oct 16, 2014 | Abandoned |
Array
(
[id] => 11778226
[patent_doc_number] => 09387262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Coated lipid complexes and their use'
[patent_app_type] => utility
[patent_app_number] => 14/507045
[patent_app_country] => US
[patent_app_date] => 2014-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 12989
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14507045
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/507045 | Coated lipid complexes and their use | Oct 5, 2014 | Issued |
Array
(
[id] => 10018562
[patent_doc_number] => 09061031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy'
[patent_app_type] => utility
[patent_app_number] => 14/488058
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 18651
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14488058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/488058 | Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy | Sep 15, 2014 | Issued |
Array
(
[id] => 10967467
[patent_doc_number] => 20140370500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'NONVIRAL TARGETED NANOPARTICLE SYSTEM FOR GENE TRANSFER AND DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/475708
[patent_app_country] => US
[patent_app_date] => 2014-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10367
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14475708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/475708 | Nonviral targeted nanoparticle system for gene transfer and drug delivery | Sep 2, 2014 | Issued |
Array
(
[id] => 11076012
[patent_doc_number] => 20160272976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'PRODUCTS AND METHODS FOR TREATMENT OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/914861
[patent_app_country] => US
[patent_app_date] => 2014-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15369
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914861 | PRODUCTS AND METHODS FOR TREATMENT OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS | Aug 25, 2014 | Abandoned |
Array
(
[id] => 13168453
[patent_doc_number] => 10100332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Biologically active synthetic nanoparticle constructs and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 14/913804
[patent_app_country] => US
[patent_app_date] => 2014-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 11
[patent_no_of_words] => 9631
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913804
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913804 | Biologically active synthetic nanoparticle constructs and methods of use thereof | Aug 24, 2014 | Issued |
Array
(
[id] => 11002714
[patent_doc_number] => 20160199663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR CONTROLLING PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/911405
[patent_app_country] => US
[patent_app_date] => 2014-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30316
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911405
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911405 | Compositions and methods for controlling pain | Aug 12, 2014 | Issued |
Array
(
[id] => 11574572
[patent_doc_number] => 09629812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Therapeutic nanoparticles and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/449590
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 44
[patent_no_of_words] => 21957
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14449590
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/449590 | Therapeutic nanoparticles and methods of use thereof | Jul 31, 2014 | Issued |
Array
(
[id] => 12111908
[patent_doc_number] => 09867885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Block copolymers'
[patent_app_type] => utility
[patent_app_number] => 14/908351
[patent_app_country] => US
[patent_app_date] => 2014-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 20
[patent_no_of_words] => 62856
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908351
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908351 | Block copolymers | Jul 29, 2014 | Issued |
Array
(
[id] => 9805267
[patent_doc_number] => 20150017211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 14/337513
[patent_app_country] => US
[patent_app_date] => 2014-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 48214
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14337513
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/337513 | Delivery and formulation of engineered nucleic acids | Jul 21, 2014 | Issued |
Array
(
[id] => 10926868
[patent_doc_number] => 20140329890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'Compounds Having Anti-Adhesive Effects on Cancer Cells'
[patent_app_type] => utility
[patent_app_number] => 14/336443
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15624
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336443 | Compounds having anti-adhesive effects on cancer cells | Jul 20, 2014 | Issued |
Array
(
[id] => 11506271
[patent_doc_number] => 09597413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Pulmonary delivery of mRNA'
[patent_app_type] => utility
[patent_app_number] => 14/308554
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19081
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308554
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/308554 | Pulmonary delivery of mRNA | Jun 17, 2014 | Issued |
Array
(
[id] => 10586685
[patent_doc_number] => 09308281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'MRNA therapy for Fabry disease'
[patent_app_type] => utility
[patent_app_number] => 14/308546
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19031
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/308546 | MRNA therapy for Fabry disease | Jun 17, 2014 | Issued |
Array
(
[id] => 14294921
[patent_doc_number] => 10287578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => DNAzyme-nanoparticle conjugates and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 14/757293
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 16
[patent_no_of_words] => 21746
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14757293
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/757293 | DNAzyme-nanoparticle conjugates and methods of use thereof | Jun 15, 2014 | Issued |